APA (7th ed.) Citation

MH, C., CW, H., HY, W., HC, P., VC, W., YK, T., & JY, C. (2026). Cardiovascular and renal outcomes of combined SGLT2 inhibitors and GLP-1 receptor agonists versus monotherapy in patients with type 2 diabetes mellitus: A network meta-analysis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 198(26), E992. https://doi.org/10.1503/cmaj.250369

Chicago Style (17th ed.) Citation

MH, Chuang, Ho CW, Wang HY, Pan HC, Wu VC, Tu YK, and Chen JY. "Cardiovascular and Renal Outcomes of Combined SGLT2 Inhibitors and GLP-1 Receptor Agonists Versus Monotherapy in Patients with Type 2 Diabetes Mellitus: A Network Meta-analysis." CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne 198, no. 26 (2026): E992. https://doi.org/10.1503/cmaj.250369.

MLA (9th ed.) Citation

MH, Chuang, et al. "Cardiovascular and Renal Outcomes of Combined SGLT2 Inhibitors and GLP-1 Receptor Agonists Versus Monotherapy in Patients with Type 2 Diabetes Mellitus: A Network Meta-analysis." CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne, vol. 198, no. 26, 2026, p. E992, https://doi.org/10.1503/cmaj.250369.